Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From ZymeTx Inc.
The rarest IPOs in recent months have been those in diagnostics, with only three completed so far this year. Nonetheless, we wondered how diagnostics companies that received the highest market caps in IPOs over the past two years fared against their smaller-cap counterparts on delivering rates of return to private investors.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Large Molecule
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.